Entry Stage: Series A

Radicle Science

Radicle Science is a healthtech public benefit corporation on a mission to transform the $1T global wellness industry by enabling rigorous science at unprecedented speed, scale, and precision. By fusing AI, consumer science, and massively scalable real world clinical trials, Radicle is enabling a new generation of proven, precision nonprescription treatments–accessible to all.

Year
Status
Entry Stage
Current Stage

Limbic

Limbic is a clinically-validated AI agent for mental healthcare, used by health systems and payers across the UK and US. The AI has supported more than 600,000 patients in treatment, and is the only AI mental health chatbot approved as a Class II medical device, supported by a growing evidence base of seven peer-reviewed studies, including in Nature Medicine.

Year
Status
Entry Stage
Current Stage

Flow Neuroscience

Flow Neuroscience is pioneering a new category of at-home electric medicine and delivering drug-free, brain-based treatments for mental health. Flow is world’s first clinically validated FDA approved at-home transcranial direct current stimulation (tDCS) headset. Since its European launch in 2019, Flow has become the only CE-marked at-home tDCS treatment for depression used by the NHS, empowering more than 55,000 people to take control of their mental health. With FDA approval in 2025, the US joins the UAE, Australia, Brazil, the UK and EU as countries where Flow’s accessible depression treatment is available.

Year
Status
Entry Stage
Current Stage

Birches Health

Birches Health is the leading national clinical program for modern digital addictions, covered by insurance and state funding. Birches Health’s mission is to provide convenient, comprehensive care and resources for individuals facing challenges related to gambling, sex and pornography, video gaming, and internet and social media addiction.

Year
Status
Entry Stage
Current Stage

Slingshot

Slingshot is the AI research lab behind Ash (www.talktoash.com), the first AI designed for therapy. By building the first foundation model for psychology Slingshot aims to make mental healthcare more accessible. The company has built dozens of domain-specific AI models for clinical mental health and tested them in a private beta with 20K+ people.

Year
Status
Entry Stage
Current Stage

Luna Joy

LunaJoy Health is a behavioral health integration company that works directly with medical doctors and payors to identify unmet service needs for women and deliver, in specialized networks, medication management, therapy and coaching.

Year
Status
Entry Stage
Current Stage

Freedom Bioscience

Freedom Biosciences is a Yale spin-out and clinical stage biotech company developing next generation depression treatments based on ketamine and 5th-based tryptamines.

Year
Status
Entry Stage
Current Stage

Attune Neurosciences

Attune Neurosciences has built a non-invasive therapeutic platform to deliver neuromodulation to the deep brain using low-intensity focused ultrasound to address a number of psychiatric, neurological and human performance applications.

Year
Status
Entry Stage
Current Stage

Pangea Bio

Pangea Bio is a biotechnology company developing transformative medicines for psychiatric and neurological disorders, by deploying AI to uncover promising molecules inspired by nature’s diverse chemical space.

Year
Status
Entry Stage
Current Stage

Vita Health

Vita Health delivers virtual therapy proven to reduce the likelihood of death by suicide by 60-80%. Vita Health is the only clinically proven, evidence-based solution focused on suicide risk reduction and prevention.

Year
Status
Entry Stage
Current Stage

Ellipsis Health

Ellipsis Health has developed the first-ever voice-based biomarker powered co-pilot for behavioral health by layering on case management, primary care, and urgent care calls. With minutes of speech, Ellipsis Health can in real-time screen for anxiety and depression and triage to different pathways based on severity.

Year
Status
Entry Stage
Current Stage

Amae Health

Amae Health is an integrated whole-person care provider specializing in treating severe mental illness (SMI), focused on personalized and lifelong treatment to deliver lasting health outcomes.

Year
Status
Entry Stage
Current Stage